Results – TransplantID

Measles Guidance Document for the Transplant Community

AST, I. D. C. of - 2025, May 31 - American Society of Transplantation

Make a difference in the field of transplantation by donating to support our cause.

Coronavirus Disease 2019 (COVID-19): Frequently Asked Questions for Transplant Candidates, Recipients, and Care Givers

AST - 2022, October 12

Information regarding COVID-19 continues to change rapidly. This document will be updated with new information whenever possible. Please contact your transplant center with specific questions or concerns. Human coronaviruses are common viruses that cause the common cold, and do not usually cause serious symptoms. A novel coronavirus named SARS-CoV-2 causes the disease called Coronavirus disease 2019 (COVID-19). This coronavirus appeared in December 2019 and quickly spread all over the...

American Society of Transplantation: COVID-19 Resources

AST - 2022, June 30

COVID-19 Vaccination Guidance For Patients

AST - 2023, March 22

Coronavirus Disease 2019 (COVID-19): FAQs for Transplant Candidates, Recipients, and Care Givers

AST - 2023, January 12

Enfermedad por Coronavirus 2019 (COVID-19): Preguntas Frecuentes para los Candidatos para Trasplantes, Recibidores y Cuidadores

AST - 2023, January 12

Comprehensive Trainee Curriculum

AST - n.d.

Timely Topics in Transplantation

AST - n.d.

Transplant in 10 (Tx10) Videos

AST - n.d.

COVID-19 Information

AST - n.d.

Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Nellore, A., Huprikar, S., & Practice, the A. I. C. of - 2019 - Clinical Transplantation, 33(9), e13549

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation address vancomycin-resistant enterococci (VRE) infections in SOT candidates and recipients. VRE are an important cause of infection and have been named by the CDC as a serious public threat. Typically, a commensal of the gastrointestinal tract, VRE may become pathogenic after abdominal organ manipulation like transplantation. This guideline reviews the microbiology,...

Endemic fungal infections in solid organ transplant recipients—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Miller, R., Assi, M., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13553

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention and management of blastomycosis, histoplasmosis, and coccidioidomycosis in the pre- and post-transplant period. Though each of these endemic fungal infections has unique epidemiology and clinical manifestations, they all share a predilection for primary pulmonary infection and may cause disseminated infection, particularly in...

Diagnosis and management of diarrhea in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Angarone, M., Snydman, D. R., & Practice, the A. I. C. of - 2019 - Clinical Transplantation, 33(9), e13550

These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of diarrhea in the pre- and post-transplant period. Diarrhea in an organ transplant recipient may result in significant morbidity including dehydration, increased toxicity of medications, and rejection. Transplant recipients are affected by a wide range of etiologies of diarrhea with the most common causes being Clostridioides...

Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Aslam, S., Rotstein, C., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13623

These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice provide recommendations for the diagnosis and management of Candida infections in solid organ transplant recipients. Candida infections manifest primarily as candidemia and invasive candidiasis and cause considerable morbidity and mortality. Early diagnosis and initiation of treatment are necessary to reduce mortality. For both candidemia and invasive candidiasis, an echinocandin...

Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice

Danziger-Isakov, L., Kumar, D., & Practice, T. A. I. C. of - 2019 - Clinical Transplantation, 33(9), e13563

These updated guidelines of the AST IDCOP review vaccination of solid organ transplant candidates and recipients. General principles of vaccination as well as the use of specific vaccines in this population are discussed. Vaccination should be reviewed in the pre-transplant setting and appropriate vaccines updated. Both inactivated and live vaccines can be given pre-transplant. The timing of vaccination post-transplant should be taken into account. In the post-transplant setting, inactivated...

Ventricular assist device-related infections and solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Koval, C. E., Stosor, V., & Practice, the A. I. C. of - 2019 - Clinical Transplantation, 33(9), e13552

The Infectious Diseases Community of Practice of the American Society of Transplantation has published evidenced-based guidelines on the prevention and management of infectious complications in SOT recipients since 2004. This updated guideline reviews the epidemiology of ventricular assist device (VAD) infections and provides recommendations for the management and prevention of these infections. Almost one half of those awaiting heart transplantation are supported with VADs. Despite advances...

BK polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Hirsch, H. H., Randhawa, P. S., & Practice, A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13528

The present AST-IDCOP guidelines update information on BK polyomavirus (BKPyV) infection, replication, and disease, which impact kidney transplantation (KT), but rarely non-kidney solid organ transplantation (SOT). As pretransplant risk factors in KT donors and recipients presently do not translate into clinically validated measures regarding organ allocation, antiviral prophylaxis, or screening, all KT recipients should be screened for BKPyV-DNAemia monthly until month 9, and then every 3...

Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Pellett Madan, R., Hand, J., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13518

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of HHV-6A, HHV-6B, HHV-7, and HHV-8 in the pre- and post-transplant period. The majority of HHV-6 (A and B) and HHV-7 infections in transplant recipients are asymptomatic; symptomatic disease is reported infrequently across organs. Routine screening for HHV-6 and 7 DNAemia is not recommended in asymptomatic patients, nor is...

Interactions between anti-infective agents and immunosuppressants—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Sparkes, T., Lemonovich, T. L., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13510

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation provide an update on potential drug-drug interactions between anti-infectives and immunosuppressants, which are most notable with calcineurin and mTOR inhibitors. Drug-drug interactions may occur through pharmacokinetic mechanisms leading to altered drug concentrations of either the anti-infective or immunosuppressive drug, or by pharmacodynamic interactions increasing or...

Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Fishman, J. A., Gans, H., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13587

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of Pneumocystis jiroveci fungal infection transplant recipients. Pneumonia (PJP) may develop via airborne transmission or reactivation of prior infection. Nosocomial clusters of infection have been described among transplant recipients. PJP should not occur during prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX)....

Your search

Results 43 resources

Filter by our tag

GUIDELINES

CORE CURRICULUM

ORGANISMS

DRUGS AND THERAPIES

PREVENTION

SYNDROMES AND CONDITIONS

SOLID ORGANS AND MCSS

HEME-ONC AND CELLULAR THERAPIES

TRANSPLANT ID TRAINING

PATIENT EDUCATION